|
× |
 |
COVID-19 and Obsessive-Compulsive Disorder: The Nightmare Just Got Real PDF |
$40.00 |
|
$40.00 |
|
× |
|
Electroconvulsive Therapy Device Classification: Response to FDA Advisory Panel Hearing and Recommendations PDF |
$40.00 |
|
$40.00 |
|
× |
|
Suicidal Behavior in Obsessive-Compulsive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Bioavailability of S-Adenosyl Methionine and Impact on Response in a Randomized, Double-Blind, Placebo-Controlled Trial in Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Exposure to Mirtazapine During Pregnancy: A Prospective, Comparative Study of Birth Outcomes PDF |
$40.00 |
|
$40.00 |
|
× |
|
Comparison of Antidepressant Use Between Subjects With Bipolar Disorder and Major Depressive Disorder With or Without Comorbid Anxiety PDF |
$40.00 |
|
$40.00 |
|
× |
|
Depression Literacy Among Dermatologists: An Online Survey Study in India PDF |
$40.00 |
|
$40.00 |
|
× |
|
High-Dose Citalopram and Escitalopram and the Risk of Out-of-Hospital Death PDF |
$40.00 |
|
$40.00 |
|
× |
|
Wernicke-Korsakoff Syndrome: A Case Series in Liaison Psychiatry PDF |
$40.00 |
|
$40.00 |
|
|
